Guangdong Taienkang Pharmaceutical Co., Ltd. (SHE:301263)
China · Delayed Price · Currency is CNY 19.09
+0.02 (0.10%)
At close: Sep 30, 2026
SHE:301263 Market Cap
SHE:301263 has a market cap or net worth of 9.7 billion as of October 2, 2026. Its market cap has decreased by -30.94% in one year.
Market Cap
9.70B
Enterprise Value
9.52B
Revenue
648.09M
Ranking
n/a
PE Ratio
n/a
Stock Price
19.09
ChartMarket Cap Chart
Since March 29, 2022, SHE:301263's market cap has increased from 8.26B to 9.70B, an increase of 17.46%. That is a compound annual growth rate of 3.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 9.70B | -20.98% |
| Dec 31, 2025 | 12.28B | 93.40% |
| Dec 31, 2024 | 6.35B | -8.63% |
| Dec 29, 2023 | 6.95B | -9.56% |
| Dec 30, 2022 | 7.68B | -6.98% |
| Mar 29, 2022 | 8.26B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shenzhen Chipscreen Biosciences | 11.16B |
| Zhejiang CONBA Pharmaceutical | 10.94B |
| Henan Lingrui Pharmaceutical | 10.76B |
| Yantai Dongcheng Pharmaceutical Group | 10.64B |
| Wedge Industrial | 10.43B |
| Tianjin Chase Sun Pharmaceutical Co.,Ltd | 9.76B |
| Ningbo Menovo Pharmaceutical | 9.72B |
| Zhejiang Jingxin Pharmaceutical | 9.71B |